Long-term prophylaxis in von Willebrand disease

Blood Coagulation and Fibrinolysis

Volumn 16, Issue SUPPL. 1, 2005, Pages

  Berntorp, Erik ^a,c   Petrini, Pia ^b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding disorders; Factor VIII; von Willebrand disease; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; VON WILLEBRAND FACTOR;

ARTHROPATHY; BLEEDING TENDENCY; DAILY LIFE ACTIVITY; EPISTAXIS; HEMARTHROSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MUCOSAL BLEEDING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SCHOOL CHILD; SWEDEN; THROMBOSIS; UNIVERSITY HOSPITAL; VIRUS TRANSMISSION; VON WILLEBRAND DISEASE;

EID: 19944364505     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000167659.23262.18     Document Type: Review

References (10)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84:160-174.
2. Berntorp E, Astermark J, Bjorkman S, Blanchette VS, Fischer K, Giangrande PL, et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003; 9(suppl 1):1-4.
3. Manco-Johnson MJ, Nuss R, Funk S, Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000; 6:649-657.
4. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30:473-483.
5. Hedner U, Ginsburg D, Lusher JM, High KA. Congenital hemorrhagic disorders: new insights into the pathophysiology and treatment of hemophilia. Hematology (Am Soc Hematol Educ Program) 2000; 241-265.
6. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Int Med 1992; 232:25-32.
7. Löfqvist T, Nillson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients - a long-term follow-up. J Int Med 1997; 241:395-400.
8. Petrini P, Lindvall N, Egberg N, Blomback M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 1991; 13:280-287.
9. Berntorp E, Lethagen S, Ljung R, Johnsson H, Petrini P, Schulman S, et al. Centralized care is the basis of care programs for hemophilia patients [in Swedish]. Lakartidningen 1999; 96:1849-1852.
10. Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105:1109-1113.